Literature DB >> 26730946

In vitro and in vivo antitumour activities of puerarin 6″-O-xyloside on human lung carcinoma A549 cell line via the induction of the mitochondria-mediated apoptosis pathway.

Ti Chen1, Hui Chen1, Ying Wang1, Jian Zhang1.   

Abstract

Context Pueraria lobata (Leguminoseae) shows cytotoxic effects against cancer cells; however, its active components remain unclear. Objective This study investigated the antitumour activity of puerarin 6″-O-xyloside (POS) on the human lung carcinoma A549 cell line. Materials and methods The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to determine the cytotoxicity of POS (at 10, 20 and 40 μM) in vitro, and xenograft nude mice were established to evaluate the antitumour effect of POS (at 40 mg/kg/d) in vivo by 15 days intraperitoneal injection (ip). To explore its mechanism of action, flow cytometry was performed to determine the pro-apoptotic effect of POS (at 10, 20 and 40 μM). Subsequently, the expression of caspase-3, caspase-7, caspase-9, Bcl-2 and Bax in A549 cells were determined. Results POS showed significant cytotoxicity toward A549 cells (p < 0.05) by inducing apoptosis. Treatment with POS significantly upregulated the levels of caspase-3 (p < 0.01), caspase-7 (p < 0.01), caspase-9 (p < 0.01) and Bax (p < 0.01) in A549 cells, and Bcl-2 was downregulated (p < 0.01). Additionally, the in vivo animal study showed that POS significantly inhibited tumour growth in A549 cells (p < 0.01). Conclusion Our study demonstrated the POS has significant antitumour activities. The mechanisms are related to increased levels of caspase-3, caspase-7, caspase-9 and Bax, and reduced levels Bcl-2.

Entities:  

Keywords:  Bcl-2; Pueraria lobata; caspase; xenograft model in nude mice

Mesh:

Substances:

Year:  2016        PMID: 26730946     DOI: 10.3109/13880209.2015.1127980

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  9 in total

1.  Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway.

Authors:  Xu Ma; Lei Yan; Qing Zhu; Fengmin Shao
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

2.  Puerarin Enhances the Anti-Tumor Effect of Cisplatin on Drug-Resistant A549 Cancer in vivo and in vitro Through Activation of the Wnt Signaling Pathway.

Authors:  Ping Huang; Shi-Xia Du
Journal:  Cancer Manag Res       Date:  2020-07-24       Impact factor: 3.989

3.  Puerarin induces cell apoptosis in human chondrosarcoma cell line SW1353 via inhibition of the PI3K/Akt signaling pathway.

Authors:  Li Huang; Junqing Cao; Lan Cao; Ling Gao; Ying Yang; Li Xu
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

4.  Puerarin 6″-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis.

Authors:  Xiao-Lan Zhang; Bin-Bin Wang; Jian-Shu Mo
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967

5.  Photoluminescent And Self-Assembled Hyaluronic Acid-Zinc Oxide-Ginsenoside Rh2 Nanoparticles And Their Potential Caspase-9 Apoptotic Mechanism Towards Cancer Cell Lines.

Authors:  Yeon Ju Kim; Haribalan Perumalsamy; Verónica Castro-Aceituno; Donghyuk Kim; Josua Markus; Seungah Lee; Sung Kim; Ying Liu; Deok Chun Yang
Journal:  Int J Nanomedicine       Date:  2019-10-09

Review 6.  Molecular Mechanisms of Anticancer Activities of Puerarin.

Authors:  Bashir Ahmad; Suliman Khan; Yang Liu; Mengzhou Xue; Ghulam Nabi; Sunjeet Kumar; Mohammed Alshwmi; Abdul Wakeel Qarluq
Journal:  Cancer Manag Res       Date:  2020-01-08       Impact factor: 3.989

7.  Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII.

Authors:  Xindong Chen; Zhiruo Zhou; Zhi Zhang; Chenhao Zhao; Jiayu Li; Jingwen Jiang; Biao Huang; Yuan Qin
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

8.  Use of Chinese Medicine Reduces the Development of Cervical Cancer from Pap Smear-Diagnosed Cervical Dysplasia: A Case-Control Study.

Authors:  Li-Ling Shen; Chih-Hsin Muo; Shan-Yu Su; Donald E Morisky
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

9.  Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.

Authors:  Long Li; Jun-Dong Liu; Guo-Dong Gao; Kai Zhang; Yu-Wei Song; Hong-Bo Li
Journal:  Cancer Med       Date:  2020-07-21       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.